• Home
  • NEW DAY MEDICINE
  • 12(50)2022
  • 19 -12 (50) 2022 — Ulmasova Shakhnoza Rakhmatdzhanovna — EFFECTIVENESS OF VARIOUS OPTIONS OF PHARMACO-DIETARY THERAPY IN PATIENTS WITH FATTY HEPATOSIS

19 -12 (50) 2022 — Ulmasova Shakhnoza Rakhmatdzhanovna — EFFECTIVENESS OF VARIOUS OPTIONS OF PHARMACO-DIETARY THERAPY IN PATIENTS WITH FATTY HEPATOSIS

EFFECTIVENESS OF VARIOUS OPTIONS OF PHARMACO-DIETARY THERAPY IN PATIENTS WITH FATTY HEPATOSIS

Ulmasova Shakhnoza Rakhmatdzhanovna Military unit 51411, Tashkent, Uzbekistan

Resume

Non-alcoholic fatty liver disease has become an urgent problem of modern hepatology due to its prevalence, diagnostic difficulties and the possibility of complications. Worldwide, the prevalence of non-alcoholic fatty liver disease averages 20-40% and is increasing every year. In connection with the development of this disease, fibrosis and cirrhosis of the liver, and in some cases, hepatocellular carcinoma, mortality increases. It has been established that 60-80% of cryptogenic cirrhosis of the liver occurs as a result of non-alcoholic steatohepatitis. Non-alcoholic fatty liver disease is the number one cause of liver transplantation worldwide.

Key words: non-alcoholic fatty liver disease, fatty liver, non-alcoholic steatohepatitis, diet, ursosan, atovastatin.

First page

122

Last page

126

For citation: Ulmasova Shakhnoza Rakhmatdzhanovna – EFFECTIVENESS OF VARIOUS OPTIONS OF PHARMACO-DIETARY THERAPY IN PATIENTS WITH FATTY HEPATOSIS //New Day in Medicine 12(50)2022 122-126 https://clck.ru/336Ux8

LIST OF REFERENCES:

  1. K.A. Komshilova, Ye.A. Troshina, Ye.V. Yershova [i dr.] Adiponektin i pokazateli metabolizma glyukozы i lipidov na raznыx kliniko-morfologicheskix stadiyax nealkogolnoy jirovoy bolezni pecheni u bolnix abdominalnыm ojireniem //Terapevticheskiy arxiv. – 2014. – № 10. – S. 27–32. [rus tilida]
  2. Alexin S.M., Somova M.N. Nealkogolnaya jirovaya bolezn pecheni: novыe vozmojnosti kombinirovannoy terapii //Farmateka. 2013. № 10 (263). S. 43-47. [rus tilida]      
  3. Ametov A.S. Saxarniy diabet 2 tipa i nealkogolnaya jirovaya bolezn pecheni: prakticheskie rekomendatsii dlya endokrinologov //Farmateka. 2013. № 5 (258). S. 58-69. [rus tilida]
  4. Axmedov V.A., Melikov T. I. Geneticheskie aspekti formirovaniya nealkogolnoy jirovoy bolezni pecheni //Lechashiy vrach. 2019. № 8. S. 28. [rus tilida]
  5. Babak O.Ya., Kolesnikova Ye.V., Shut I.V. Vzaimosvyaz mejdu soderjaniem adiponektina, visseralnogo jira i polimorfnim genom ADIPOR1 u bolnix nealkogolnoy jirovoy boleznyu pecheni //Sovremennaya gastroenterologiya. 2012. № 5 (67). S. 7-12.       [rus tilida]
  6. Balukova Ye.V., Uspenskiy Yu.P. Nealkogolnaya jirovaya bolezn pecheni i metabolicheskiy sindrom //Poliklinika. 2014. № 2. S. 45-48. [rus tilida]
  7. Baskov, S.S. Nealkogolnaya jirovaya bolezn podjeludochnoy jelezi kak digestivniy marker metabolicheskogo sindroma / S.S. Baskov, G.A. Pronina, D.I. Injevatkin // Med.-biol. i sos.-psixol. problemi bezopasnosti v chrezvichaynix situatsiyax. – 2012. – № 4. – S. 50–55. [rus tilida]
  8. Bivalkevich N.V. Zakonomernosti strukturno-funksionalnoy reorganizatsii pecheni pri formirovanii diet-indutsirovannoy nealkogolnoy jirovoy bolezni pecheni u kris: dissertatsiya … kandidata biologicheskix nauk: 03.03.04 / Bivalkevich Nataliya Vladimirovna; Tixookeanskiy gosudarstvenniy meditsinskiy universitet.- Vladivostok, 2015.- 127 s. [rus tilida]
  9. Bobronnikova L.R., Juravlyova A.K. Mexanizmi progressirovaniya dislipidemii u patsientov s nealkogolnoy jirovoy boleznyu pecheni //Ukrainskiy terapevticheskiy jurnal. 2013. № 2 (37). S. 083-088. [rus tilida]
  10. Vakalyuk I.I., Virstyuk N.G., Kazmiruk V.M. Progressirovanie fibroza pecheni u bolnix so stabilnoy ishemicheskoy boleznyu serdsa na fone nealkogolnoy jirovoy bolezni pecheni //Gastroenterologiya. 2016. № 4 (62). S. 27-31. [rus tilida]

file

download